Ekkehard Moessner

Ekkehard Moessner has extensive experience in the pharmaceutical and biotechnology industry. Ekkehard currently holds the position of VP Biologics Discovery at Ridgeline Discovery since November 2022. Previously, they worked at Roche Pharmaceuticals as a Scientist from an unknown start date to November 2022. Prior to that, they were a Research Scientist at Glycart Biotechnology AG from March 2003 to July 2005, where they initiated the Protein Engineering Group and was involved in humanization of antibodies and engineering of bispecific molecules.

Ekkehard Moessner completed their education with a Diploma in Chemistry from Universität Karlsruhe. Ekkehard then pursued a PhD in Molecular Biology and Biophysics from ETH Zürich, followed by postdoctoral studies in Biochemistry at the University of Zurich. Additionally, they obtained a Master of Science in Structural Molecular Biology from Birkbeck, University of London in 2009.